Research Article

Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer

Figure 9

YYD inhibits NSCLC tumor growth. A549 cells were subcutaneously implanted into nude mice to establish the transplantation tumor models of NSCLC. After 6 days, mice were intragastrically administered with YYD daily. (a) Tumor growth was examined every 3 days. (b) Tumor weight. (c) The expression of proteins associated with EGFR-PI3K-AKT signaling. (d) IHC staining for p-EGFR, Ki-67, cyclin D1, and Bax in xenograft tumors. , , and versus the control group.
(a)
(b)
(c)
(d)